HAL (France)open access
Comparable outcomes with anti-thymocyte globulins versus basiliximab in kidney transplantation from controlled circulatory death donors
1, Induction, 2, 0, Delayed graft function, Antithymocyte globulin, Basiliximab, DCD donation after circulatory death
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 268780
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.